Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
In 56-week studies, patients taking Contrave alongside diet and exercise lost an average of 5-9% of their body weight, compared to 1-5% with a placebo, meaning the medication contributed roughly 4-5 percentage points of additional weight loss.4,5 About 46% of patients on Contrave achieved at least 5% weight loss by week 16
Early-phase clinical trial data for retatrutide have generated considerable interest within the medical and scientific community, primarily due to the scale of weight loss observed in participants
Ashley Koff, RD 00:39:30 Thats going to be the point where Im going to say, okay, we got to stop
Pushing through significant joint pain is counterproductive
-Mounjaro is a brand name for the drug tirzepatide, which is a dual GIP and GLP-1 receptor agonist, meaning it activates two hormone pathways instead of one
US$ 25.00
US$ 27.52
US$ 27.88
US$ 28.51
US$ 20.07
